<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: To investigate how intense <z:e sem="disease" ids="C0858318" disease_type="Disease or Syndrome" abbrv="">Plasmodium falciparum infection</z:e> predisposes to Epstein-Barr virus (EBV)-positive Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), we analyzed the effect of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> on existing EBV-host balance </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: EBV genome loads in peripheral blood mononuclear cells were assayed by quantitative polymerase chain reaction, and EBV-specific CD8(+) T cell responses were assayed by interferon-gamma enzyme-linked immunospot assay </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Gambian children, from whom samples were obtained during an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> attack and again up to 6 weeks later, had extremely high <z:mp ids='MP_0001799'>viral</z:mp> loads, reaching levels that in the United Kingdom are seen only in patients with <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Gambian control subjects (children and adults with no recent history of <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>) had lower median <z:mp ids='MP_0001799'>viral</z:mp> loads, although they were still &gt;10-fold above the median for healthy UK adults </plain></SENT>
<SENT sid="4" pm="."><plain>Limited experiments with EBV <z:chebi fb="0" ids="53000">epitope</z:chebi> <z:chebi fb="7" ids="16670">peptides</z:chebi> (restricted through the HLA-B 3501 and HLA-B 5301 alleles) also suggested an impairment of virus-specific CD8(+) T cell function in children with <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>, but only during <z:hpo ids='HP_0011009'>acute</z:hpo> disease </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0011009'>Acute</z:hpo> <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> is associated with sustained increase in EBV load and, possibly, a transient decrease in EBV-specific T cell surveillance </plain></SENT>
<SENT sid="6" pm="."><plain>We infer that the unusually high set point of virus carriage in P. falciparum-challenged populations, allied with the parasite's capacity to act as a <z:hpo ids='HP_0011010'>chronic</z:hpo> B cell stimulus, probably contributes to the pathogenesis of endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>